Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Cardiology|November 26, 2016
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatmentRobert Dufour, Jean Bergeron, Daniel Gaudet, et al.
Metabolism: Clinical and Experimental|December 12, 2003
Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variablesCharles Couillard, Jean Bergeron, Jean-Pierre Després, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2019
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated StatinDirk Müller-Wieland, Daniel J Rader, Patrick M Moriarty, et al.
Metabolism: Clinical and Experimental|January 14, 2003
Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adultsArthur Weltman, Jean Pierre Despres, Jody L Clasey, et al.
Atherosclerosis|September 9, 2020
Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experienceSumayah Aljenedil, Latifah Alothman, Alexandre M Bélanger, et al.
The Journal of Nutrition|October 2, 2003
High carbohydrate and high monounsaturated fatty acid diets similarly affect LDL electrophoretic characteristics in men who are losing weightW Roodly Archer, Benoît Lamarche, Annie C St-Pierre, et al.
Molecular Genetics and Metabolism|December 20, 2011
Genetic contribution to C-reactive protein levels in severe obesityGeneviève Faucher, Frédéric Guénard, Luigi Bouchard, et al.
Pageof 18